RAYONIER ADVANCED MATERIALS INC. current report, 18 September 2015

Business Context and Reporting Period

Company: Rayonier Advanced Materials Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 18, 2015 (Event Date); Signed September 23, 2015
Context: The Company reported the entry into a material definitive agreement involving an amendment to a long-standing supply contract.

Key Financial Metrics

This filing is a current report regarding a contractual agreement and does not contain financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.

Material Changes and Agreements

  • Agreement: Amendment to Chemical Cellulose Agreement.
  • Parties: Rayonier A.M. Sales and Technology Inc. (RYST, a subsidiary) and Nantong Cellulose Fibers Co., Ltd. ("Nantong").
  • Effective Date: January 1, 2016.
  • Background: Amends the original Cellulose Specialties Agreement dated January 1, 2012.
  • Confidentiality: The Company has requested confidential treatment under Rule 24b-2 to redact specific portions of the Amendment. A redacted copy is attached as Exhibit 10.1.

Guidance, Outlook, and Management Commentary

The filing references a press release issued on September 23, 2015, titled "Rayonier Advanced Materials Announces Major Contract Extension" (Exhibit 99.1). The filing itself does not provide specific forward-looking guidance, quantitative outlook, or detailed management commentary regarding the financial impact of the amendment beyond the description of the agreement.

Investor Verification Checklist

  • Review the redacted Exhibit 10.1 to understand the scope of the redacted terms.
  • Read the full text of the September 23, 2015 press release (Exhibit 99.1) for details on the "Major Contract Extension."
  • Verify the strategic importance of the Nantong relationship to the Company's cellulose specialties segment.
  • Monitor future filings for the unredacted terms if the confidential treatment request is denied or expires.